Related Experiment Video
Updated: Mar 27, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Contribution of hypertension to recent changes in cardiovascular disease mortality: a population-based study in the
Cande V Ananth1,2,3,4, Jessica C Fields5,6, Rachel Lee1
1Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Insights
Cardiovascular disease (CVD) mortality linked to hypertension (HTN) is rising in the US. Public health strategies are needed to address this concerning trend in CVD-HTN deaths.
Area of Science:
- Cardiovascular medicine
- Public health
- Epidemiology
Background:
- Hypertension is a major risk factor for cardiovascular disease (CVD).
- The specific impact of hypertension on CVD mortality trends in the U.S. requires further investigation.
- Understanding the role of hypertension as a secondary cause of CVD mortality is crucial for public health initiatives.
Purpose of the Study:
- To assess trends in cardiovascular disease (CVD) mortality with hypertension (HTN) as a secondary cause (CVD-HTN) in the United States from 2000 to 2022.
- To determine the proportion of CVD mortality attributed to concomitant hypertension in males and females.
- To analyze changes in age-standardized mortality rates for CVD with and without secondary hypertension.
Main Methods:
- Sequential time-series analysis of U.S. mortality data from 2000 to 2022.
- Examination of age-standardized mortality rates (18-84 years) for CVD as the underlying cause.
- Calculation of CVD-HTN mortality rates and the proportionate fraction of CVD deaths with secondary hypertension.
Main Results:
- CVD-HTN mortality rates increased in both females (47.4 to 52.4 per 100,000) and males (67.3 to 96.2 per 100,000) from 2000 to 2022.
- The proportion of CVD deaths attributed to hypertension rose significantly in both sexes, reaching 34.8% in females and 36.2% in males by 2022.
- Conversely, CVD mortality rates without concomitant hypertension declined substantially in both females and males over the study period.
Conclusions:
- The increasing trend of CVD mortality associated with hypertension is a significant public health concern.
- These findings highlight the growing burden of hypertension as a contributing factor to cardiovascular deaths.
- Consideration of targeted public health interventions to mitigate hypertension-related CVD mortality is warranted.
Objectives:
Hypertension remains a persistent global challenge and is an essential risk factor for cardiovascular disease (CVD). However, the extent to which hypertension is implicated in CVD mortality in the United States remains unknown. We assessed CVD mortality trends with hypertension as a secondary cause (CVD-HTN) and the proportion of CVD mortality in those with and without secondary hypertension.
Methods:
We designed a sequential time-series analysis to examine trends in age-standardized mortality rates (18-84 years) with CVD as the underlying cause, with and without concomitant hypertension (as a secondary cause), in the United States from 2000 to 2022. We examined changes in CVD-HTN mortality rates (per 100 000 individuals). We assessed the proportionate fraction of CVD mortality in patients with and without hypertension as a secondary cause.
Results:
Among females, CVD-HTN mortality rates have increased from 47.4 in 2000 to 52.4 per 100 000 in 2022. CVD mortality rates without concomitant hypertension among females declined from 189.9 in 2000 to 98.0 per 100 000 in 2022. CVD-HTN mortality rates among males increased from 67.3 in 2000 to 96.2 per 100 000 in 2022. CVD mortality rates without concomitant hypertension among males declined over the same period (339.4 in 2000 to 169.9 per 100 000 in 2022). Among females in 2000 and 2022, 20 and 34.8% of CVD deaths were due to concomitant hypertension; among males, these estimates were 16.5 and 36.2%, respectively.
Conclusion:
The increase in CVD mortality associated with concomitant hypertension is concerning. Public health efforts to mitigate this increase may be worth considering.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Errors occurring during blood pressure monitoring
Several factors...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...

